Both maternal IFNγ exposure and acute prenatal infection with Toxoplasma gondii activate fetal hematopoietic stem cells

• DOI: 10.15252/embj.2022112693
• Publication Date: 2023-06-01T07:21:41Z
• Authors: Diego A López; Kelly S Otsuka; April C Apostol; Jasmine Posada; Juan C Sánchez‐Ar...; Kirk DC Jensen; Anna E Beaudin
• Keywords: Inflammation; 570; 500; Toxoplasma gondii; Cell Differentiation; Articles; Hematopoietic Stem Cells; hematopoiesis; 3. Good health; congenital infection; inflammation; Pregnancy; Humans; hematopoietic stem cell; Female; Toxoplasma; Toxoplasmosis

AbstractInfection directly influences adult hematopoietic stem cell (HSC) function and differentiation, but the fetal hematopoietic response to infection during pregnancy is not well‐studied. Here, we investigated the fetal hematopoietic response to maternal infection with Toxoplasma gondii (T. gondii), an intracellular parasite that elicits Type II IFNγ‐mediated maternal immunity. While it is known that maternal infection without direct pathogen transmission can affect fetal immune development, the effects of maternal IFNγ on developing HSCs and the signals that mediate these interactions have not been investigated. Our investigation reveals that the fetal HSCs respond to T. gondii infection with virulence‐dependent changes in proliferation, self‐renewal potential, and lineage output. Furthermore, maternal IFNγ crosses the fetal–maternal interface, where it is perceived by fetal HSCs. By comparing the effects of maternal IFNγ injection with maternal T. gondii infection, we reveal that the effects of IFNγ treatment mimic some aspects of the fetal HSC response to infection. Moreover, our findings illuminate that the fetal HSC response to prenatal infection is distinct from the adult HSC response to IFNγ‐induced inflammation. Altogether, our data disentangle the role of infection‐induced inflammatory cytokines in driving the expansion of downstream hematopoietic progenitors.